Tuberous sclerosis complex (TSC) is a genetic disorder characterized by multi-system hamartomas, which occur from mutations of the TSC1/TSC2 genes and subsequent overactivation of the mammalian target of rapamycin (mTOR) signaling pathway and dysregulation of cell proliferation (Orlova and Crino, 2010). This evidence concerns the gene TSC1 and hereditary disease.